Skip to main content
Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.65
+0.21 (1.36%)
Mar 9, 2026, 1:23 PM EDT - Market open

Pharming Group Revenue

Pharming Group had revenue of $97.29M in the quarter ending September 30, 2025, with 29.98% growth. This brings the company's revenue in the last twelve months to $362.27M, up 26.78% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.

Revenue (ttm)
$362.27M
Revenue Growth
+26.78%
P/S Ratio
2.92
Revenue / Employee
$896,718
Employees
404
Market Cap
1.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024297.20M51.88M21.15%
Dec 31, 2023245.32M39.69M19.30%
Dec 31, 2022205.62M6.75M3.39%
Dec 31, 2021198.87M-13.30M-6.27%
Dec 31, 2020212.17M22.79M12.03%
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xeris Biopharma Holdings 291.85M
Geron 183.88M
UroGen Pharma 109.79M
AbCellera Biologics 75.13M
Inventiva 19.93M
Precigen 6.31M
Aktis Oncology 5.56M
DBV Technologies 5.50M
Revenue Rankings

PHAR News

More News